SCHEMBL7177488

SCHEMBL7177488

COc1c(C)c(C(=O)N(C)C)c(C(=O)N(C)C)c(OC)c1C=CC(=O)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
MAPT P10636 5/20 0.45
BCHE P06276 3/20 0.45
NPC1 O15118 3/20 0.45
RAB9A P51151 3/20 0.45
LMNA P02545 2/20 0.45
NFKB1 P19838 1/20 0.45
NFKB2 Q00653 1/20 0.45
RELA Q04206 1/20 0.45
ABCG2 Q9UNQ0 1/20 0.44
ABCB1 P08183 1/20 0.43
TNFRSF1A P19438 2/20 0.42
ALDH1A1 P00352 5/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
HSPD1 P10809 1/20 0.42
MAOB P27338 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7184759 0.87 CYP3A4 (0.44) CYP3A4CYP1A2CYP2C9CYP2C19MAPT
SCHEMBL7185114 0.85 CYP3A4 (0.43) CYP3A4CYP1A2CYP2C9CYP2C19MAPT
SCHEMBL7804215 0.85 TNFRSF1A (0.48) CYP3A4CYP1A2CYP2C9CYP2C19MAPT
SCHEMBL7177399 0.83 CYP3A4 (0.41) CYP3A4CYP1A2CYP2C9CYP2C19MAPT
SCHEMBL7177330 0.81 TNFRSF1A (0.40) CYP3A4CYP1A2CYP2C9CYP2C19MAPT
SCHEMBL7178875 0.81 TNFRSF1A (0.49) CYP3A4CYP1A2CYP2C9CYP2C19MAPT
SCHEMBL8146123 0.78 MAPT (0.59) CYP3A4CYP1A2CYP2C9CYP2C19MAPT
SCHEMBL7196529 0.74 ABCG2 (0.56) CYP3A4CYP1A2CYP2C9CYP2C19MAPT
SCHEMBL7190221 0.74 CYP3A4 (0.49) CYP3A4CYP1A2CYP2C9CYP2C19MAPT
SCHEMBL7196533 0.74 ABCG2 (0.56) CYP3A4CYP1A2CYP2C9CYP2C19MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed
EP-0634927-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1995-01-25 EP disclosed
WO-1993017671-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1993-09-16 WO disclosed